Tirzepatides imbalanced receptor engagement, which favors GIP receptor activation, combined with biased signaling at the GLP-1 receptor, further enhances insulin secretion and metabolic benefits (35, 36)
Despite these challenges, GLP-1 RAs still show great potential as part of the standard treatment for patients with OSA complicated by obesity and/or T2DM
Its a smart question and one many people are starting to ask
Retatrutide may be considered in individuals such as: Obesity Metabolic syndrome Weight loss plateau Suboptimal response to semaglutide or tirzepatide High visceral fat levels Those aiming for fat loss while preserving lean muscle mass Suitability should always be evaluated under physician supervision
Key points: We need to eat in a calorie deficit to lose weight If our baseline diet is rich in ultra-processed foods and we continue to eat this way on semaglutide, we may still consume more calories than we need to lose weight Its essential to eat a diet based on whole foods to support sustainable weight loss 2) Youre in a weight-loss plateau Suppose weve lost some weight on semaglutide, but then we hit a plateau, and we cant budge the scales any more
Therefore, NCL urges consumers to learn about the safety risks associated with non-standard forms of GLP-1s and to heed these warnings from the FDA and medical authorities: Microdosing a GLP-1 drug means intentionally taking a smaller dose than what the FDA approved as the standard dosage levels for the treatment of obesity or diabetes based on clinical studies
